Sickle cell is a disorder of the haemoglobin in the red blood cells. There are an estimated 18,000 people with the disease in the UK and 3 million globally.
Sickle Cell Genomics PSP
About the Sickle Cell Genomics Priority Setting Partnership
Genomics England and the Sickle Cell Society will work with patients, carers, carriers and healthcare professionals to identify uncertainties about the relationship between Sickle Cell and Genomics for example, how Sickle Cell progresses in individuals, new treatment developments and links between severity and risk, and understand the uncertainties in the practices used in this field of research.
Key Documents
These documents set out the aims, objectives and commitments of the PSP.